Clinical Trial Update: Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing esomeprazole 20 mg once daily with ranitidine 150 mg twice daily in NSAID-induced gastric ulcers; the study's efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Ranitidine (Ranitidine)

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2010-07-08